Ginkgo Bioworks

View All

The Business cocktail 16 may
Ginkgo to buy mining platform; Vertex, Kymera collaborate; ArcherDX nets $60M; Bayer to invest $150M

Ginkgo announces to buy Warp Drive Bio’s genome mining platform Ginkgo Bioworks has announced to acquire the genome mining platform from Warp Drive Bio, a subsidiary of REVOLUTION Medicines.  The acquisition will give Gingko access to Warp Drive Bio's genome mining team, technology, and database. This coll...

Find More